Bleeding News and Research

RSS

Biogen announces FDA acceptance of rFIXFc BLA for treatment of hemophilia B

Biogen Idec announced today that the U.S. Food and Drug Administration (FDA) has accepted the company's Biologics License Application (BLA) for the marketing approval of recombinant factor IX Fc fusion protein (rFIXFc) for the treatment of hemophilia B and granted the company a standard review timeline.

5 Mar 2013

Screening colonoscopy associated with reduced advanced colorectal cancer diagnoses

A new study led by a researcher at the Perelman School of Medicine at the University of Pennsylvania adds support to current medical recommendations stating that screening colonoscopy substantially reduces an average-risk adult's likelihood of being diagnosed with advanced colorectal cancer (CRC) in either the right or left side of the colon.

4 Mar 2013

FDA approves Tenaxis Medical’s ArterX Surgical Sealant

Tenaxis Medical, Inc., a medical device company focused on the development of functionally designed surgical sealants has received FDA approval to bring its innovative ArterX Surgical Sealant to the market.

4 Mar 2013

Colonoscopy is also safe, confirms German Cancer Research Center study

Colon cancer develops slowly. Precancerous lesions usually need many years to turn into a dangerous carcinoma. They are well detectable in an endoscopic examination of the colon called colonoscopy and can be removed during the same examination. Therefore, regular screening can prevent colon cancer much better than other types of cancer.

3 Mar 2013

Radiation, surgery offer best survival possibilities for metastatic gastric cancer patients

Researchers at Moffitt Cancer Center studied patients with metastatic gastric cancer and found that those who have both surgery and radiation have better survival than those who receive one or no form of treatment.

28 Feb 2013

Baxter files FEIBA NF BLA with FDA for prophylactic treatment of hemophilia A or B

Baxter International Inc. today announced that the company has submitted a biologics license application (BLA) supplement to the U.S. Food and Drug Administration (FDA) for the approval of prophylaxis treatment of FEIBA NF [Anti-Inhibitor Coagulant Complex], Nanofiltered and Vapor Heated, in patients with hemophilia A or B and inhibitors.

From Baxter International Inc. 26 Feb 2013

Shionogi receives FDA approval for Osphena to treat women with severe dyspareunia

The U.S. Food and Drug Administration today approved Osphena (ospemifene) to treat women experiencing moderate to severe dyspareunia (pain during sexual intercourse), a symptom of vulvar and vaginal atrophy due to menopause.

26 Feb 2013

Complementary medicine risks: an interview with Dr Andrew Boyden, NPS MedicineWise

Complementary medicines include products containing herbs, vitamins, minerals, nutritional supplements, homoeopathic medicines, certain aromatherapy products and traditional Chinese medicines. For this reason they are also called herbal, natural or alternative medicines.

26 Feb 2013

Bayer receives FDA approval for Stivarga to treat advanced gastrointestinal stromal tumors

The U.S. Food and Drug Administration today expanded the approved use of Stivarga (regorafenib) to treat patients with advanced gastrointestinal stromal tumors (GIST) that cannot be surgically removed and no longer respond to other FDA-approved treatments for this disease.

26 Feb 2013

WOEST supports clopidogrel only in PCI patients on anticoagulation

Publication of the WOEST trial results reaffirm the study’s major finding that antiplatelet therapy with clopidogrel alone is preferable to the use of both aspirin and clopidogrel in patients undergoing percutaneous coronary intervention who are receiving oral anticoagulant therapy.

25 Feb 2013

ABCDE criteria non optimal for pediatric melanoma diagnosis

Conventional criteria for diagnosing melanoma may not be accurate in children and adolescents, suggest results published in the Journal of the American Academy of Dermatology.

25 Feb 2013

COPD has negative prognostic impact in heart attack patients

Chronic obstructive pulmonary disease is associated with an increased risk for death and hospital readmission for cardiovascular causes in patients with ST-segment elevation myocardial infarction, research shows.

25 Feb 2013

Physicians afraid to give thrombolytic drugs to pulmonary embolism patients for good reason

When doctors encounter a patient with a massive pulmonary embolism, they face a difficult choice: Is it wise to administer a drug that could save the patient's life, even though many people suffer life-threatening bleeding as a result? Based on new findings published in the American Journal of Medicine, Michigan State University researchers are answering that question in no uncertain terms.

22 Feb 2013

Dabigatran decreases risk of recurrent venous thromboembolism

New findings from two double-blind, randomized trials, RE-MEDY and RE-SONATE, show that dabigatran 150 mg twice daily reduces the risk of recurrent venous thromboembolism (VTE).

21 Feb 2013

Study assesses ischaemic and haemorrhagic risk linked with history of stroke or TIA

Heart and cerebro-vascular disorders represent the two leading causes of death throughout the world. They are sometimes combined in a single patient and their combination represents both a considerable risk to the patient and a therapeutic challenge.

20 Feb 2013

CARHY successfully conducts urology surgery through HOLEP 100 watt laser technique

Columbia Asia Referral Hospital, Yeshwanthpur (CARHY) successfully conducted a Urology surgery through an advanced laser technology - HOLEP. The team of doctors led by Dr Manohar, Consultant Urologist at CARHY removed a large prostate gland weighing 350 gms, hitherto unheard of in medical history.

18 Feb 2013

Researchers explore cellular signals produced by the body in response to traumatic injury

When it comes to healing the terrible wounds of war, success may hinge on the first blood clot - the one that begins forming on the battlefield right after an injury. Researchers exploring the complex stream of cellular signals produced by the body in response to a traumatic injury believe the initial response - formation of a blood clot - may control subsequent healing.

18 Feb 2013

Epic Wound Care enters beta test agreement with Ryan Network for UEEC's hemostatic gauze

United Health Products, Inc.'s www.unitedhealthproductsinc.com wholly owned subsidiary, Epic Wound Care, Inc., which develops and markets products and technologies in the healthcare sector, is pleased to announce that it has entered into a beta test agreement with the distinguished Ryan Network for UEEC's hemostatic gauze. The gauze is registered and branded in the USA under the trademark HemoStyp.

15 Feb 2013

New progestogen-only treatment effective in stopping acute abnormal uterine bleeding

New research from the Los Angeles Biomedical Research Institute (LA BioMed) found a progestogen-only treatment halted bleeding in women suffering from extremely heavy periods, according to the study published online by the American Journal of Obstetrics and Gynecology.

15 Feb 2013

Rivaroxaban ruled out for extended thromboprophylaxis

The benefits of extended prophylactic anticoagulation with rivaroxaban in acutely ill hospital patients are outweighed by an increased bleeding risk, shows a study in The New England Journal of Medicine.

14 Feb 2013

Bleeding News and Research

Biogen announces FDA acceptance of rFIXFc BLA for treatment of hemophilia B

Screening colonoscopy associated with reduced advanced colorectal cancer diagnoses

FDA approves Tenaxis Medical’s ArterX Surgical Sealant

Colonoscopy is also safe, confirms German Cancer Research Center study

Radiation, surgery offer best survival possibilities for metastatic gastric cancer patients

Baxter files FEIBA NF BLA with FDA for prophylactic treatment of hemophilia A or B

Shionogi receives FDA approval for Osphena to treat women with severe dyspareunia

Complementary medicine risks: an interview with Dr Andrew Boyden, NPS MedicineWise

Bayer receives FDA approval for Stivarga to treat advanced gastrointestinal stromal tumors

WOEST supports clopidogrel only in PCI patients on anticoagulation

ABCDE criteria non optimal for pediatric melanoma diagnosis

COPD has negative prognostic impact in heart attack patients

Physicians afraid to give thrombolytic drugs to pulmonary embolism patients for good reason

Dabigatran decreases risk of recurrent venous thromboembolism

Study assesses ischaemic and haemorrhagic risk linked with history of stroke or TIA

CARHY successfully conducts urology surgery through HOLEP 100 watt laser technique

Researchers explore cellular signals produced by the body in response to traumatic injury

Epic Wound Care enters beta test agreement with Ryan Network for UEEC's hemostatic gauze

New progestogen-only treatment effective in stopping acute abnormal uterine bleeding

Rivaroxaban ruled out for extended thromboprophylaxis

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News